Skip to main content

Table 1 Clinical characteristics of patients with malignant tumors, benign tumors, thrombi and pseudotumors

From: Evaluation of cardiac masses by real-time perfusion imaging echocardiography

Variables Malignant (n = 23) Benign (n = 24) Thrombi (n = 33) Pseudotumors (n = 6) P
Age (years) 45.7 ± 19.2 46.8 ± 19.3 53.0 ± 16.2 52.5 ± 11.0
Female gender 12 (52.2%) 16 (64%) 17 (51.5%) 4 (57.1%)
Weight (Kg) 69.2 ± 20.6 63.0 ± 20.0 63.11 ± 11.5 77.7 ± 21.3
Height (cm) 165.6 ± 12.2 158.9 ± 13.7 164.0 ± 9.2 163.2 ± 10.1
Body mass index (Kg/m2) 24.8 ± 5.3 24.4 ± 6.2 23.4 ± 3.4 29.1 ± 7.1
Cardiovascular history
  Hypertension 7 (30.4%) 13 (52%) 15 (45.5%) 3 (42.8%)
  Diabetes 4 (17.4%) 4 (16%) 4 (12.1%) 2 (28.6%)
  Coronary artery disease 1 (4.3%) 3 (12%) 9 (27.3%) 1 (14.3%)
  Dilated cardiomyopathy 0 1 (4%) 9 (27.3%) 2 (28.6%) *
  Congestive heart failure 3 (13.0%) 4 (16%) 17 (51.5%) 3 (42.8%) *
  Atrial fibrillation 1 (4.3%) 1 (4%) 4 (12.1%) 0
  Embolic event 2 (8.7%) 0 4 (12.1%) 0
  Cerebrovascular accident 1 (4.3%) 4 (16%) 3 (9.0%) 1 (14.3%)
  Valvular heart disease 1 (4.3%) 1 (4%) 9 (27.3%) 0 *
Signs and symptoms
  Dyspnea 15 (65.2%) 5 (20%) 22 (66.7%) 3 (42.8%) †§
  Fever 1 (4.3%) 0 2 (6.0%) 1 (14.3%)
  Peripheral edema 8 (34.8%) 0 10 (30.3%) 2 (28.6%)
  Dysphagia 4 (17.4%) 1 (4%) 0 0 *
  Chest pain 7 (30.4%) 5 (20%) 3 (9.0%) 1 (14.3%)
  Syncope 1 (4.3%) 1 (4%) 0 0
  Odynophagia 3 (13.0) 0 0 0
  Weight loss 12 (52.2%) 0 7 (21.2%) 0
  Lipothymia 4 (17.4%) 2 (8%) 2 (6.0%) 0
  1. † = not significant between groups; * = p < 0.001 between malignant tumors, benign tumors, thrombi and pseudotumors; § = p < 0.05 between malignant tumors and benign tumors.